|
Quotes & Info
|
| CBMC.OB > SEC Filings for CBMC.OB > Form 8-K on 16-Dec-2008 | All Recent SEC Filings |
16-Dec-2008
Change in Directors or Principal Officers
(b) On December 5, 2008, Calypte Biomedical Corporation (the "Company") and Donald N. Taylor, the Company's Chief Executive Officer and Chief Financial Officer, mutually agreed to terminate Mr. Taylor's employment and employment agreement.
|
|